ArticleObesity (Silver Spring, Md.)2026
Trends in Diagnosing Obesity: The CALOR Study.
Article in Obesity (Silver Spring, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study aimed to describe characteristics of people with elevated BMI by presence versus absence of obesity diagnosis and trends over time.
methodsData from adults with recorded BMI ≥ 30 kg/m
resultsIn the United States (N = 3,584,120; 70.1% with obesity diagnosis), prevalence of interrelated diseases was high overall and higher in those with versus without obesity diagnosis, e.g., type 2 diabetes (49.3% vs. 29.9%), chronic kidney disease (32.9% vs. 18.8%), and heart failure (23.3% vs. 9.8%). In Japan (N = 3,140,900; 2.3% with obesity diagnosis), interrelated disease burden was also higher in those with versus without obesity diagnosis, e.g., type 2 diabetes (42.2% vs. 25.9%) and chronic kidney disease (14.3% vs. 8.6%). In the United States, interrelated disease burden was generally higher for those first diagnosed in 2024 versus those diagnosed in 2016-2020.
conclusionsIn people with elevated BMI in the United States and Japan, there was underdiagnosis of obesity and a high prevalence of interrelated diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.